Develop tools that use genetic data to better classify complex human diseases

This project aims to develop novel statistical tools for classifying heterogeneous diseases like epilepsy and schizophrenia using genetic information to enhance precision medicine.

Subsidie
€ 1.975.333
2023

Projectdetails

Introduction

Many common diseases are highly heterogeneous, meaning that two individuals can be diagnosed with the same disease but have very different progressions or respond very differently to the same medication. These heterogeneous diseases affect a sizeable proportion of the population. For example, approximately one in four people will develop a heterogeneous brain disorder (e.g., a neurological condition such as epilepsy or Parkinson’s Disease, or a psychiatric condition such as depression or schizophrenia).

Need for Improved Classification

To effectively treat a patient with a heterogeneous disease, it is necessary to quickly and accurately identify their subtype. At present, patient subtypes are decided using only clinical observations, and the process is highly suboptimal.

  • The available subtypes are often incomplete or poorly defined.
  • Many patients are wrongly classified or cannot be classified at all.

Incorporating Genetic Information

Previous research indicates that for many heterogeneous diseases, the classification of patients can be improved by incorporating genetic information. However, for this to become a reality, it requires statistical tools that do not yet exist.

Project Goals

My project will develop novel statistical tools for classifying heterogeneous diseases based on genetic information.

Focus Areas

My project will prioritize classification of two heterogeneous diseases:

  1. Epilepsy
  2. Schizophrenia

However, I will ensure that my new tools are general, freely available, and easy to use, so that other groups can construct classification models for many other diseases.

Potential Impact

Overall, my project has the potential to revolutionize how patients with heterogeneous diseases are treated and to facilitate more widespread use of precision medicine.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.975.333
Totale projectbegroting€ 1.975.333

Tijdlijn

Startdatum1-8-2023
Einddatum31-7-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • AARHUS UNIVERSITETpenvoerder

Land(en)

Denmark

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC STG

Subtype as a key to reduce heterogeneity of treatment effects in major depressive disorder

SUBTREAT aims to enhance treatment for major depressive disorder by identifying subtypes through advanced data science, exploring their causes, and developing predictive algorithms for tailored therapies.

€ 1.500.000
ERC STG

Genetically anchored drug target discovery for neglected diseases

GenDrug aims to develop innovative algorithms integrating genomic and real-world data to identify drug targets and accelerate drug development for neglected non-communicable diseases.

€ 1.498.089
ERC POC

GenomeDia: a personalized medicine tool for diabetes

The project aims to develop a genetic interpretation tool to subcategorize young diabetes patients, enhancing treatment by leveraging findings from whole genome sequencing.

€ 150.000
MIT Haalbaarheid

Genotype Landscape een big data gedreven platform voor zeldzame genetische ziektes

Het project richt zich op het ontwikkelen van een platform voor marktonderzoek dat bedrijven helpt bij het nauwkeurig inschatten van doelgroepen voor therapieën van zeldzame erfelijke ziektes.

€ 20.000